Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Polarity Health - Testing & Market Preparation

Reference number
Coordinator Polarity Health AB
Funding from Vinnova SEK 135 983
Project duration November 2025 - June 2026
Status Completed
Venture Innovative Startups
Call Innovative Startups 2025

Important results from the project

During the project we carried out development activities, recruitment of test participants, a regulatory mapping and market preparation activities, including a delegation trip to Germany. The project was then ended early, which meant the full validation and launch plan were not completed. The work generated valuable insights into user needs, the technical conditions and the regulatory pathway.

Expected long term effects

The need for early warning signals in bipolar disorder remains and affects a large group of users, relatives and healthcare providers. The insights gained on data collection, regulatory requirements and market conditions reduce the risk in future development work. In the longer term a validated solution can contribute to fewer relapses, lower care burden and higher quality of life for the target group.

Approach and implementation

The project began in November 2025 and was run by a small team supported by clinical and regulatory advisers. Several activities were completed as planned, including development work, recruitment of test participants, regulatory mapping and market preparation.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 3 July 2026

Reference number 2025-01999